Sarcomatoid-variant renal cell carcinoma: Treatment outcome and survival in advanced disease
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Renal Cell
Metastatic sarcomatoid-variant RCC was associated with a poor response to systemic therapy. Sunitinib treatment resulted in a modest response rate, but studies to characterize the underlying tumor biology of sarcomatoid-variant RCC, to assess outcome to targeted agents, and to develop novel treatment strategies are warranted.